Israel Englander’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-483,742
| Closed | -$2.51M | – | 6190 |
|
|
2025
Q4 | $2.51M | Buy |
483,742
+400,514
| +481% | +$1.94M | ﹤0.01% | 3741 |
|
|
2025
Q3 | $351K | Sell |
83,228
-55,752
| -40% | -$259K | ﹤0.01% | 5271 |
|
|
2025
Q2 | $509K | Sell |
138,980
-22,071
| -14% | -$82.3K | ﹤0.01% | 4900 |
|
|
2025
Q1 | $696K | Sell |
161,051
-47,369
| -23% | -$191K | ﹤0.01% | 4615 |
|
|
2024
Q4 | $667K | Buy |
208,420
+5,765
| +3% | +$19.3K | ﹤0.01% | 4524 |
|
|
2024
Q3 | $580K | Buy |
202,655
+68,812
| +51% | +$193K | ﹤0.01% | 4712 |
|
|
2024
Q2 | $375K | Sell |
133,843
-76,913
| -36% | -$206K | ﹤0.01% | 4780 |
|
|
2024
Q1 | $599K | Sell |
210,756
-735,458
| -78% | -$2.5M | ﹤0.01% | 4698 |
|
|
2023
Q4 | $3.87M | Sell |
946,214
-373,714
| -28% | -$1.05M | ﹤0.01% | 3011 |
|
|
2023
Q3 | $4.2M | Sell |
1,319,928
-859,158
| -39% | -$2.73M | ﹤0.01% | 2855 |
|
|
2023
Q2 | $7.23M | Buy |
2,179,086
+594,812
| +38% | +$1.76M | ﹤0.01% | 2328 |
|
|
2023
Q1 | $3.38M | Sell |
1,584,274
-142,988
| -8% | -$353K | ﹤0.01% | 2955 |
|
|
2022
Q4 | $4.65M | Buy |
1,727,262
+231,733
| +15% | +$676K | ﹤0.01% | 2876 |
|
|
2022
Q3 | $4.85M | Buy |
1,495,529
+929,727
| +164% | +$4.2M | ﹤0.01% | 2915 |
|
|
2022
Q2 | $2.76M | Sell |
565,802
-856,176
| -60% | -$5.27M | ﹤0.01% | 3382 |
|
|
2022
Q1 | $10.8M | Buy |
1,421,978
+227,852
| +19% | +$1.76M | 0.01% | 2073 |
|
|
2021
Q4 | $11M | Buy |
1,194,126
+698,263
| +141% | +$7.42M | 0.01% | 2043 |
|
|
2021
Q3 | $7.06M | Sell |
495,863
-494,584
| -50% | -$7.68M | ﹤0.01% | 2479 |
|
|
2021
Q2 | $16.5M | Buy |
990,447
+758,062
| +326% | +$14.1M | 0.01% | 1385 |
|
|
2021
Q1 | $4.23M | Buy |
232,385
+135,384
| +140% | +$1.83M | ﹤0.01% | 2764 |
|
|
2020
Q4 | $730K | Buy |
+97,001
| New | +$461K | ﹤0.01% | 3938 |
|
|
2020
Q2 | – | Sell |
-78,956
| Closed | -$255K | – | 4482 |
|
|
2020
Q1 | $255K | Sell |
78,956
-82,830
| -51% | -$355K | ﹤0.01% | 3265 |
|
|
2019
Q4 | $778K | Buy |
+161,786
| New | +$1.03M | ﹤0.01% | 3118 |
|
|
2019
Q3 | – | Sell |
-16,878
| Closed | -$128K | – | 4454 |
|
|
2019
Q2 | $128K | Sell |
16,878
-42,337
| -71% | -$311K | ﹤0.01% | 3854 |
|
|
2019
Q1 | $444K | Buy |
+59,215
| New | +$1.18M | ﹤0.01% | 3342 |
|
|
2018
Q3 | – | Sell |
-500,000
| Closed | -$5.01M | – | 4176 |
|
|
2018
Q2 | $5.01M | Buy |
+500,000
| New | +$5.01M | 0.01% | 1818 |
|
Other funds holding ORGO
SCM
FLAM
Israel Englander's ORGO Position: Q1 2026 in Review
Israel Englander sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 483,742 shares — an estimated $2.51M sold.
Israel Englander first reported a position in ORGO in Q2 2018 and held it in 26 quarters. The position peaked at $16.5M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.
- Israel Englander reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
- Israel Englander sold 483,742 Organogenesis Holdings shares in Q1 2026, an estimated $2.51M.
- Israel Englander first reported a position in Organogenesis Holdings in Q2 2018 and held it in 26 quarters.
- Israel Englander's Organogenesis Holdings position peaked at $16.5M in Q2 2021.
- 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.